LGLOX | RGEBX | LGLOX / RGEBX | |
Total Expense Ratio | 0.59 | 1.09 | 54% |
Annual Report Gross Expense Ratio | 0.59 | 1.09 | 54% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 15.015 | 14.166 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.76B | 328B | 2% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 37.20 | 13.67 | 272% |
Returns for 3 years | 90.87 | 52.58 | 173% |
Returns for 5 years | 31.57 | 33.24 | 95% |
Returns for 10 years | N/A | 94.86 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 65.70 | 0.10 | +0.15% |
Janus Henderson Global Life Sciences S | |||
CMJIX | 44.46 | -0.17 | -0.38% |
Calvert US Mid Cap Core Rspnb Idx I | |||
ARVIX | 13.01 | -0.08 | -0.61% |
ARGA International Value Institutional | |||
RICAX | 64.59 | -0.42 | -0.65% |
American Funds Invmt Co of Amer R1 | |||
JACFX | 19.60 | -0.21 | -1.06% |
JHancock Mid Cap Growth NAV |